{"basic_info": {"ticker": "6855", "exchange": "XHKG", "bloomberg_ticker": "6855 HK Equity", "name": "ASCENTAGE PHARMA GROUP INTER", "industry": "Biotechnology", "name_chinese_simplified": "亚盛医药", "period": "2020", "market_value": 8248729088, "total_income": 12450000, "ccy": "人民币元", "shariah_compliance_summary": "compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 12450000, "business_income_over_total_income": 1.0}, {"shariah_compliance": "unknown", "income": 0, "business_income_over_total_income": 0.0}], "details": [{"business_activity_cn": "研发服务费收入", "business_activity_en": "R & D service fee income", "income": 2574000, "business_income_over_total_income": 0.20674698795180724, "shariah_compliance": "compliant"}, {"business_activity_cn": "许可费收入", "business_activity_en": "License fees", "income": 9876000, "business_income_over_total_income": 0.7932530120481928, "shariah_compliance": "compliant"}, {"business_activity_cn": "未分配", "business_activity_en": "Unassigned", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.05737922109804702, "shariah_compliance": "compliant", "amount_over_market_value": 0.05737922109804702}]}